NEW YORK (360Dx) – Novacyt today announced regulatory actions by US and Chinese regulators for two of its products.

In the US, the firm has registered its Novaprep HQ+ Orange vial as a class I device with the US Food and Drug Administration. Providers who can qualify the vial for cytology or molecular use in the US can now purchase the product. Novacyt plans to seek a commercialization partner for the Novaprep vial and media system, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.